icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
Safety, Antiviral Efficacy, and Pharmacokinetics
of Sofosbuvir in Patients With Severe Renal Impairment

 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
Edward J. Gane,1 Richard A. Robson,2 Maurizio Bonacini,3 Benedict Maliakkal,4 Brian Kirby,5 Lin Liu,5 Karim Sajwani,5
Luisa M. Stamm,5 Diana M. Brainard,5 John G. McHutchison,5 Catherine A. Stedman,6 Eric Lawitz7
1Univeristy of Auckland, Auckland, New Zealand; 2Christchurch Clinical Studies Trust, Christchurch, New Zealand; 3California Pacific Medical Center, San Francisco, CA; 4University of Rochester, Rochester, NY;
5Gilead Sciences, Inc., Foster City, CA; 6Christchurch Hospital, Christchurch, New Zealand; 7The Texas Liver Institute, San Antonio, TX

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif